Iomeron

Iomeprol, the active ingredient in Iomeron, is an iodinated contrast agent presented as a sterile solution for intra‑arterial, intrathecal and intravenous use. It enhances radiographic visualization during diagnostic imaging procedures such as angiography and computed tomography, and is employed in patients undergoing vascular or organ imaging studies to provide clear delineation of anatomical structures.

GNH USA supplies Iomeron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company provides regulatory‑approved batches, comprehensive documentation, and logistics support to meet global clinical demand.

Iomeron is used as an iodinated contrast medium to improve image quality in vascular and cross‑sectional imaging procedures.

Angiography: enhances visualization of blood vessels, allowing detailed assessment of arterial and venous anatomy. Computed Tomography (CT) imaging: increases contrast between tissues, facilitating detection of lesions and organ pathology. Cardiac CT: provides clear delineation of coronary arteries and cardiac chambers for functional and anatomical evaluation.

Iomeron may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: transient feeling of sickness often occurring during or shortly after injection. - Warm sensation: brief flushing or feeling of heat at the injection site. - Metallic taste: temporary metallic flavor in the mouth. - Mild headache: short‑lasting headache following administration.

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergic response that can include airway obstruction, hypotension, and shock. - Acute kidney injury: sudden deterioration of renal function, particularly in patients with pre‑existing kidney disease. - Cardiac arrhythmia: abnormal heart rhythm that may require monitoring or intervention.

Prior to using Iomeron, clinicians should observe several precautionary measures to minimize risk. - Assess renal function: evaluate serum creatinine and eGFR before administration. - Review allergy history: identify prior reactions to iodinated contrast or iodine‑containing substances. - Ensure adequate hydration: encourage fluid intake or intravenous hydration to protect kidney function. - Monitor vital signs: observe blood pressure and heart rate during and after injection. - Discontinue metformin temporarily: hold metformin in patients at risk of contrast‑induced nephropathy. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Iomeron can interact with certain medications, influencing safety or efficacy.

Major Interactions (Avoid): - Metformin: risk of lactic acidosis in patients with impaired renal function after contrast exposure. - Thyroid hormone therapy: excess iodine may alter thyroid hormone levels, leading to hyper‑ or hypothyroidism. - Radioactive iodine therapy: iodine load can interfere with therapeutic efficacy.

Moderate Interactions (Monitor Closely): - NSAIDs: concurrent use may increase risk of contrast‑induced nephropathy; monitor renal parameters. - Diuretics: may exacerbate volume depletion and renal impairment; ensure adequate hydration.